Rapid Micro Biosystems, Inc. RPID
0.74 USD 0.00 (-0.31%)
Regular-session close
0.74 0.00 +0.48%
After hours · Nov 19, 4:00 PM ET
0.7353 Day range 0.7366
0.58 52-week range 4.94
- YTD
- -74.64%
- 1 year
- -83.14%
News
prnewswire.com SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Rapid Micro Biosystems, Inc. (NASDAQ: RPID) NEW YORK, Nov. 18, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is…
prnewswire.com Are GLND, RPID, AYTU Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
globenewswire.com BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Aytu BioPharma, Inc. (Nasdaq – AYTU), Rapid Micro Biosystems, Inc. (Nasdaq – RPID), Advantage Energy Ltd. (OTC – AAVVF), Canaccord Genuity Group Inc. (OTC – CCORF) BALA CYNWYD, Pa., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky…
businesswire.com RPID Stock Alert: Halper Sadeh LLC is Investigating Whether Rapid Micro Biosystems, Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Rapid Micro Biosystems, Inc. (NASDAQ: RPID) to Merck KGaA, Darmstadt, Germany for $0.75 per…
globenewswire.com RPID Shareholder Alert: ADEMI LLP Investigates Whether Buyout Fairly Values Rapid Micro Biosystems, Inc. RPID shareholders will receive just $0.75 per share in an all-cash transaction; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers
zacks.com Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Beats Revenue Estimates Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.26 per share a year ago.
globenewswire.com Merck KGaA, Darmstadt, Germany Signs Definitive Agreement to Acquire Rapid Micro Biosystems, Advancing Automation in Pharmaceutical Quality Control Darmstadt, Germany, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Proposed acquisition would strengthen company's quality-control workflow offering with Rapid Micro Biosystems' Growth Direct® automated microbial…benzinga.com Rapid Micro Biosystems Q3 EPS $(0.23) Misses $(0.20) Estimate, Sales $9.528M Miss $10.000M Estimate Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.20) by 15 percent. This is a 11.54 percent increase over losses…
benzinga.com Merck KGaA Agrees To Acquire Rapid Micro Biosystems At Price Of $0.75/Shr In All-Cash Transaction Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing…
globenewswire.com Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results LEXINGTON, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation…
globenewswire.com Rapid Micro Biosystems Signs Definitive Agreement to be Acquired by Merck KGaA, Darmstadt, Germany LEXINGTON, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation…
zacks.com Rapid Micro Biosystems, Inc. (RPID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Rapid Micro Biosystems (RPID) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 8.9% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $10.1 million. Tenax Therapeutics…
globenewswire.com Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026 LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation…
globenewswire.com Rapid Micro Biosystems to Participate in Upcoming Investor Conferences LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation…
zacks.com After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID) Rapid Micro Biosystems (RPID) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street…
zacks.com Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID) The heavy selling pressure might have exhausted for Rapid Micro Biosystems (RPID) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall…
defenseworld.net Many Bright Ideas Technologies (OTCMKTS:MBGNF) versus Rapid Micro Biosystems (NASDAQ:RPID) Head to Head Contrast Many Bright Ideas Technologies (OTCMKTS:MBGNF - Get Free Report) and Rapid Micro Biosystems (NASDAQ: RPID - Get Free Report) are both healthcare companies, but which is the superior stock? We will…
zacks.com Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock? Rapid Micro Biosystems (RPID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
seekingalpha.com Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call Transcript Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call Transcript
marketbeat.com Rapid Micro Biosystems Q2 Earnings Call Highlights Rapid Micro Biosystems NASDAQ: RPID reported second-quarter revenue of $8.1 million, up 11% from $7.3 million a year earlier and above the company's prior guidance, as consumable sales, service…
zacks.com Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.27 per share a year ago.
globenewswire.com Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results Reports second quarter 2026 total revenue of $8.1 million , representing 11% growth compared to the second quarter of 2025 Achieved a significant milestone with the 200th Growth Direct system placed…
